Home » Topics » Conferences

Conferences
RSS

Selectin inhibitor effective in animal model of early- and late-phase airways inflammation

May 16, 1997

Preclinical studies demonstrate antiinflammatory effects of selective PDE IV inhibitor

May 16, 1997

ABT-080 effective in animal model of lung eosinophilia

May 16, 1997

In vitro characterization of novel CysLTD1 receptor antagonist

May 16, 1997

Endothelin receptor blockade for airways inflammation

May 16, 1997

Airways-selective inhaled steroid for the treatment of asthma

May 16, 1997

New hypoxic cytotoxin from Evanston Hospital

May 15, 1997

PAK-104P reverses both P-glycoprotein- and MRP-mediated MDR

May 15, 1997

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...